Skip to main content

Glimepiride

NDC 43547-395 · Solco Healthcare U.S., LLC

Generic nameglimepiride
Dosage formTABLET
RouteORAL
Active ingredient(s)GLIMEPIRIDE
Strength2 mg/1
Pharmacologic classSulfonylurea Compounds [CS], Sulfonylurea [EPC]
Marketing categoryANDA

Packages

43547-395-10 — 100 TABLET in 1 BOTTLE, PLASTIC (43547-395-10)

43547-395-50 — 500 TABLET in 1 BOTTLE, PLASTIC (43547-395-50)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

42571-105 — Glimepiride, 43063-121 — Glimepiride, 43063-122 — Glimepiride, 43063-587 — Glimepiride, 43063-630 — Glimepiride, 43063-697 — Glimepiride, 43063-698 — Glimepiride, 43063-699 — Glimepiride, 43063-946 — Glimepiride, 43547-394 — glimepiride, 43547-396 — glimepiride, 50090-1006 — Glimepiride, 50090-6322 — Glimepiride, 50090-6394 — Glimepiride, 50090-6415 — Glimepiride, 50090-6426 — Glimepiride, 50090-6852 — Glimepiride, 50090-6910 — Glimepiride, 50090-7187 — Glimepiride, 50090-7246 — Glimepiride, +86 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels